164 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B N/A
Article Searches
M&A, Innovation & New Drugs to Drive Pharma Stocks http://www.zacks.com/commentary/152408/ma-innovation-new-drugs-to-drive-pharma-stocks?cid=CS-ZC--152408 Mar 08, 2018 - M&A, Innovation & New Drugs to Drive Pharma Stocks
Rule Breaker February Mailbag: Reflections on the Fool's Own ETF, Plus Some Un-Foolish Investing Woes https://www.fool.com/investing/2018/03/07/rule-breaker-february-mailbag-reflections-on-the-f.aspx?source=iedfolrf0000001 Mar 07, 2018 - Some listeners to the podcast are interested in the Fool 100 Index. Others have questions and stories that cut to the heart our investing philosophy.
4 Buy-Ranked Large Cap Pharma Stocks to Boost Your Portfolio http://www.zacks.com/stock/news/294071/4-buy-ranked-large-cap-pharma-stocks-to-boost-your-portfolio?cid=CS-ZC-FT-294071 Feb 28, 2018 - Though the large-cap pharma sector struggled a little after a strong start in 2018, it is largely expected to rebound as the year progresses.
Pfizer Gets Mixed Feedback on Cancer Treatments From CHMP http://www.zacks.com/stock/news/293908/pfizer-gets-mixed-feedback-on-cancer-treatments-from-chmp?cid=CS-ZC-FT-293908 Feb 27, 2018 - CHMP recommends in favor of two hematology medicines of Pfizer (PFE) while recommending against label expansion of kidney cancer drug, Sutent.
Pharma Stock Roundup: AZN's Imfinzi Gets 2nd FDA Nod, MRK to Buy Australian Firm http://www.zacks.com/stock/news/293455/pharma-stock-roundup-azns-imfinzi-gets-2nd-fda-nod-mrk-to-buy-australian-firm?cid=CS-ZC-FT-293455 Feb 23, 2018 - Key announcements this week included the FDA approval for a second indication of AstraZeneca's (AZN) Imfinzi and an acquisition offer by Merck (MRK).
Eurozone Beats United States Again: 5 Hot Stock Picks http://www.zacks.com/stock/news/293079/eurozone-beats-united-states-again-5-hot-stock-picks?cid=CS-ZC-FT-293079 Feb 21, 2018 - 5 Europe-based stocks to buy as the region scores decade-high growth rate in 2017.
The Zacks Analyst Blog Highlights: Nordisk, TJX, Cigna, Regeneron and ArcelorMittal http://www.zacks.com/stock/news/292909/the-zacks-analyst-blog-highlights-nordisk-tjx-cigna-regeneron-and-arcelormittal?cid=CS-ZC-FT-292909 Feb 20, 2018 - The Zacks Analyst Blog Highlights: Nordisk, TJX, Cigna, Regeneron and ArcelorMittal
Top Research Reports for Novo Nordisk, TJX Companies & Cigna http://www.zacks.com/research-daily/149587/top-research-reports-for-novo-nordisk-tjx-companies-cigna?cid=CS-ZC-FT-149587 Feb 16, 2018 - Top Research Reports for Novo Nordisk, TJX Companies & Cigna
Better Buy: Pfizer Inc. (PFE) vs. Eli Lilly (LLY) https://www.fool.com/investing/2018/02/11/better-buy-pfizer-inc-pfe-vs-eli-lilly-lly.aspx?source=iedfolrf0000001 Feb 11, 2018 - Which of these giant drugmakers is the better stock to buy, now that they've been knocked down a few pegs?
Novo Nordisk's Dichotomy Abounds https://www.fool.com/investing/2018/02/06/novo-nordisks-dichotomy-abounds.aspx?source=iedfolrf0000001 Feb 06, 2018 - It's a tale of two cities for the diabetes specialist.

Pages: 123456789101112...17

<<<Page 7>